BS — 13th Biosimilars Congregation 2019

13th Biosimilars Congregation 2019 will provide insight into the current state of play in the EU and stimulate debate, in a multi-stakeholder setting, on the vital role of biosimilar medicines in the sustainability of healthcare systems. Beyond a comprehensive outlook of key European market access policies, our speakers will outline the key recent developments in regulatory science and regulatory policy in the EU and other international jurisdictions. Special emphasis will be placed on strengthening the link between regulators and medical communities as an essential basis for greater understanding and acceptance of biosimilar medicines. This Biosimilars conference will focus on multiple aspects of Biosimilar product development to successfully deliver safe, Biosimilar products to the market place. By attending this conference, you will gain a comprehensive outlook on the key issues surrounding Biosimilars. This event will provide an important platform for Biosimilars stakeholders to discuss and share best practices in furthering Biosimilars development.

Topics: Biosimilars, Biologics, Biotechnology, Biogenerics, Biopharmaceuticals, Biotherapeutics, Follow on Biologics, Follow on Proteins, Legal Affairs, Intellectual Property, Process Control and Analytical Technologies, Chief Scientific Officer, Principal Scientist, Clinical Immunology, Pricing and Reimbursement